EUVIMEDEUVIMED entdecken
Open Access

Combination of Urinary MiR-501 and MiR-335 With Current Clinical Diagnostic Parameters as Potential Predictive Factors of Prostate Biopsy Outcome

Jaroslav Juracek, Marie Madrzyk, Karolina Trachtova, Michaela Ruckova, Julia Bohosova, Dominik A Barth, Martin Pichler, Michal Stanik, Ondrej Slaby

Cancer Genomics - Proteomics · 2023

DOI: 10.21873/cgp.20383 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Genomics - Proteomics, 2023. Verfasst von Jaroslav Juracek und 8 weiteren Autor:innen. Beteiligte Einrichtung: Central European Institute of Technology, Masaryk University, Brno, Czech Republic. Hauptthemen laut MEDLINE: Prostatic Neoplasms, MicroRNAs, Prostatic Hyperplasia. Die Arbeit wurde bisher 5-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Prostatic NeoplasmsMicroRNAsProstatic HyperplasiaMaleHumansProstateProstate-Specific AntigenBiomarkers, TumorBiopsy

Stichwörter der Autor:innen

NGSProstate cancerdiagnosismiRNA ratiomicroRNAnon-invasiveprostate biopsyregression modelurine

Substanzen

Prostate-Specific AntigenBiomarkers, TumorMicroRNAsMIRN335 microRNA, humanMIRN501 microRNA, human

Autor:innen und Institutionen

  • Central European Institute of Technology, Masaryk University, Brno, Czech Republic.
  • Research Unit of Non-Coding RNAs and Genome Editing in Cancer, Division of Clinical Oncology, Department of Medicine, Comprehensive Cancer Center Graz, Medical University of Graz, Graz, Austria.
  • Department of Urologic Oncology, Clinic of Surgical Oncology, Masaryk Memorial Cancer Institute, Brno, Czech Republic; stanik@mou.cz.
  • Central European Institute of Technology, Masaryk University, Brno, Czech Republic; ondrej.slaby@ceitec.muni.cz.
  • Department of Biology, Faculty of Medicine, Masaryk University, Brno, Czech Republic.

Zitieren

APA

Juracek, J., Madrzyk, M., Trachtova, K., Ruckova, M., Bohosova, J., Barth, D. A., Pichler, M., Stanik, M., & Slaby, O. (2023). Combination of Urinary MiR-501 and MiR-335 With Current Clinical Diagnostic Parameters as Potential Predictive Factors of Prostate Biopsy Outcome. Cancer Genomics - Proteomics. https://doi.org/10.21873/cgp.20383

Vancouver

Juracek J, Madrzyk M, Trachtova K, Ruckova M, Bohosova J, Barth DA, et al. Combination of Urinary MiR-501 and MiR-335 With Current Clinical Diagnostic Parameters as Potential Predictive Factors of Prostate Biopsy Outcome. Cancer Genomics - Proteomics. 2023. doi:10.21873/cgp.20383

BibTeX
@article{Juracek2023,
  author = {Juracek, Jaroslav and Madrzyk, Marie and Trachtova, Karolina and Ruckova, Michaela and Bohosova, Julia and Barth, Dominik A and Pichler, Martin and Stanik, Michal and Slaby, Ondrej},
  title = {Combination of Urinary MiR-501 and MiR-335 With Current Clinical Diagnostic Parameters as Potential Predictive Factors of Prostate Biopsy Outcome},
  journal = {Cancer Genomics - Proteomics},
  year = {2023},
  doi = {10.21873/cgp.20383}
}
Kostenlos starten →